Skip to content

Cancer Health Center

Font Size

Histopathologic, Immunologic, and Cytogenetic Characteristics of LCH

    continued...

    Etiology

    The etiology of LCH is unknown. Efforts to define a viral cause have not been successful.[8,9] One study has shown that 1% of patients have a positive family history for LCH.[10]

    Cytogenetic and Genomic Studies

    Studies showing clonality in LCH using polymorphisms of methylation-specific restriction enzyme sites on the X-chromosome regions coding for the human androgen receptor, DXS255, PGK, and HPRT were published in 1994.[11,12] Biopsies of lesions with single-system or multisystem disease were found to have a proliferation of LCH cells from a single clone. Pulmonary LCH in adults is usually nonclonal.[13] Cytogenetic abnormalities in LCH have rarely been reported. One study described an abnormal clone t(7;12)(q11.2;p13) from a vertebral lesion of one patient.[14] This study also reported nonclonal karyotypic abnormalities in three patients. An increase in chromosomal breakage was also noted.

    Comparative genomic hybridization has been used to analyze bone and pulmonary LCH cells with conflicting results.[13,15,16,17] Thus, there is some doubt if comparative genomic hybridization can reliably identify mutations in LCH.

    One report has shown significantly shortened telomeres in lesional LCH cells compared with LCs in inflammatory disorders such as dermatopathic lymphadenitis.[18] However, another group found telomere length of LCH cells from skin multisystem lesions were long compared with those from bone lesions that were heterogeneous in length.[19] Telomerase was more often expressed in skin LCH lesions than in bone lesions. In another study evaluation of peripheral blood leukocyte DNA from high-risk LCH patients showed polymorphisms of two cytokine genes (IL-4 and interferon gamma), which were associated with high-expressor phenotypes.[20]

    Activating mutation of the BRAF gene (V600E) was detected in 35 of 61 (57%) LCH biopsy samples, with mutations being more common in patients younger than 10 years (76%) than in patients aged 10 years and older (44%).[21] Activating BRAF mutations are also found in selected nonmalignant conditions (e.g., benign nevi) [22] and low-grade malignancies (e.g., pilocytic astrocytoma).[23,24] All of these conditions have in common a generally indolent course with spontaneous resolution sometimes occurring. This distinctive clinical course may be a manifestation of oncogene-induced senescence.[22,25]

    1|2|3|4

    Today on WebMD

    Colorectal cancer cells
    A common one in both men and women.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Do you know the symptoms?
     
    Jennifer Goodman Linn self-portrait
    Blog
    what is your cancer risk
    HEALTH CHECK
     
    colorectal cancer treatment advances
    Video
    breast cancer overview slideshow
    SLIDESHOW
     
    prostate cancer overview
    SLIDESHOW
    lung cancer overview slideshow
    SLIDESHOW
     
    ovarian cancer overview slideshow
    SLIDESHOW
    Actor Michael Douglas
    Article